雪榕生物(300511.SZ):控股股東將變更為萬紫千鴻、實控人將變更為蔣智 3月13日起復牌
格隆匯3月12日丨雪榕生物(300511.SZ)公佈,2025年3月12日,上海雪榕生物科技股份有限公司控股股東、實際控制人楊勇萍先生與上海萬紫千鴻智能科技有限公司(簡稱“萬紫千鴻”)簽署了《關於上海雪榕生物科技股份有限公司之控制權變更框架協議》),約定本次交易由楊勇萍先生及其一致行動人浙江銀萬私募基金管理有限公司-銀萬華奕1號私募證券投資基金(簡稱(“銀萬華奕1號”)將部分股份轉讓給萬紫千鴻、楊勇萍先生剩餘全部股份表決權委託給萬紫千鴻及萬紫千鴻現金認購公司向特定對象發行的新股三部分組成。同日,上述相關主體分別簽署了《股份轉讓協議》、《表決權委託協議》和《附條件生效的股份認購協議》。《股份轉讓協議》和《表決權委託協議》生效後,公司的控股股東及實際控制人將發生變化,公司的控股股東將變更為萬紫千鴻,實際控制人將變更為蔣智先生。
公司股票(證券代碼:300511,證券簡稱:雪榕生物)及可轉換公司債券(債券代碼:123056,債券簡稱:雪榕轉債)自2025年3月13日(星期四)開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.